News Focus
News Focus
icon url

BBalls-N-CowTown

03/30/21 5:48 PM

#155735 RE: BreezeWoodAcres #155734

It’s all about understanding “half-life”, how the drug spends. If CD12 dosage hadn’t been capped a lot of those over 65 patients would be alive today. Geez, let the doctors practice real medicine and treat their patients. Obviously the case study of that patient recovering with 4 doses after 84 days on ECMO made them look carefully at the CD12 data again.
icon url

justdafactss

03/30/21 5:48 PM

#155736 RE: BreezeWoodAcres #155734

Wheres the SEC 8-K filing of todays PR?

icon url

ClosetInvestor

03/30/21 5:55 PM

#155738 RE: BreezeWoodAcres #155734

“The pipeline is stacked and by the end of the week 1.3 million vials will be spoken for.”

Let’s come back to this on Friday.
icon url

tikotiko

03/30/21 6:20 PM

#155741 RE: BreezeWoodAcres #155734

Yep, plus it is becoming clear that Leronlimab is the best therapeutic. It is clearly superior to those by HGEN and RLFTF, and the market is starting to recognize this despite the games, agendas and other BS.
CYDY LONG!
icon url

mjbaker84

03/30/21 6:21 PM

#155744 RE: BreezeWoodAcres #155734

Please elaborate